«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:

期数:

2022年05期

页码:

742-745

栏目:

综述

出版日期:

2022-10-20

文章信息/Info

Title:

-

作者:

何晓梅; 姜 露; 张克斌; 余 华

400037 重庆,陆军(第三)军医大学第二附属医院临床医学研究中心

Author(s):

-

关键词:

肿瘤微环境;  非小细胞肺癌;  肿瘤相关巨噬细胞;  相互作用

Keywords:

-

分类号:

R734.2

DOI:

10.3877/cma.j.issn.1674-6902.2022.05.036

摘要:

-

Abstract:

-

参考文献/References:

1 李慧婷, 莫冉冉, 宋 鹏, 等. 非小细胞肺癌免疫检查点抑制剂治疗进展[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(3): 382-386.
2 吴国明, 钱桂生. 非小细胞肺癌靶向治疗研究进展及新理念[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(4): 405-408.
3 Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021[J]. CA Cancer J Clin, 2017, 71(1): 7-33.
4 Inamura K. Lung Cancer: Understanding its molecular pathology and the 2015 WHO classification[J]. Front Oncol, 2017, 7: 193.
5 Morrissey SM, Zhang F, Ding C, et al. Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming[J]. Cell Metab, 2021, 33(10): 2040-2058.e10.
6 Ettinger DS, Wood DE, Aisner DL, et al. Pivotal involvement of the CX3CL1-CX3CR1 axis for the recruitment of M2 tumor-associated macrophages in skin carcinogenesis[J]. J Natl Compr Canc Netw, 2021, 19: 254-266.
7 Pan Y, Yu Y, Wang X, et al. Tumor-associated macrophages in tumor immunity[J]. Front Immunol, 2020, 11: 583084.
8 Sumitomo R, Hirai T, Fujita M, et al. M2 tumor-associated macrophages promote tumor progression in non-small-cell lung cancer[J]. Exp Ther Med, 2019, 18(6): 4490-4498.
9 Jackute J, Zemaitis M, Pranys D, et al. Distribution of M1 and M2 macrophages in tumor islets and stroma in relation to prognosis of non-small cell lung cancer[J]. BMC Immunol, 2018, 19(1): 3.
10 Larionova I, Tuguzbaeva G, Ponomaryova A, et al. Tumor-associated macrophages in human breast, colorectal, lung, ovarian and prostate cancers[J]. Front Oncol, 2020, 10: 566511.
11 Xu F, Wei Y, Tang Z, et al. Tumor-associated macrophages in lung cancer: Friend or foe?(Review)[J]. Mol Med Rep, 2020, 22(5): 4107-4115.
12 Najafi M, Hashemi Goradel N, Farhood B, et al. Macrophage polarity in cancer: A review[J]. J Cell Biochem, 2019, 120(3): 2756-2765.
13 Sedighzadeh SS, Khoshbin AP, Razi S, et al. A narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implications[J]. Transl Lung Cancer Res, 2021, 10(4): 1889-1916.
14 Yonemitsu K, Miyasato Y, Shiota T, et al. Soluble factors involved in cancer cell-macrophage interaction promote breast cancer growth[J]. Anticancer Res, 2021, 41(9): 4249-4258.
15 Hara T, Chanoch-Myers R, Mathewson ND, et al. Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma[J]. Cancer Cell, 2021, 39(6): 779-792.e11.
16 Yang C, Dou R, Wei C, et al. Tumor-derived exosomal microRNA-106b-5p activates EMT-cancer cell and M2-subtype TAM interaction to facilitate CRC metastasis[J]. Mol Ther, 2021, 29(6): 2088-2107.
17 Miller M, Hanna N. Advances in systemic therapy for non-small cell lung cancer[J]. Bmj, 2021, 375: n2363.
18 Nagano T, Tachihara M, Nishimura Y. Molecular mechanisms and targeted therapies including immunotherapy for non-small cell lung cancer[J]. Curr Cancer Drug Targets, 2021, 19(8): 595-630.
19 Chen R, Manochakian R, James L, et al. Emerging therapeutic agents for advanced non-small cell lung cancer[J]. J Hematol Oncol, 2020, 13(1): 58.
20 Wu K, Lin K, Li X, et al. Redefining tumor-associated macrophage subpopulations and functions in the tumor microenvironment[J]. Front Immunol, 2020, 11: 1731.
21 Malfitano AM, Pisanti S, Napolitano F, et al. Tumor-associated macrophage status in cancer treatment[J]. Cancers(Basel), 2020, 12(7): 1987.
22 Boutilier AJ, Elsawa SF. Macrophage polarization states in the tumor microenvironment[J]. Int J Mol Sci, 2021, 22(13): 6995.
23 Schmall A, Al-Tamari HM, Herold S, et al. Macrophage and cancer cell cross-talk via CCR2 and CX3CR1 is a fundamental mechanism driving lung cancer[J]. Am J Respir Crit Care Med, 2015, 191(4): 437-447.
24 Colegio OR, Chu NQ, Szabo AL, et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid[J]. Nature, 2015, 513(7519): 559-563.
25 Pritchard A, Tousif S, Wang Y, et al. Lung tumor cell-derived exosomes promote M2 macrophage polarization[J]. Cells, 2020, 9(5): 1303.
26 Li BH, Garstka MA, Li ZF. Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor[J]. Mol Immunol, 2020, 117: 201-215.
27 Fei L, Ren X, Yu H, et al. Targeting the CCL2/CCR2 Axis in Cancer Immunotherapy: One Stone, Three Birds?[J]. Front Immunol, 2021, 12: 771210.
28 Korbecki J, Kojder K, Simińska D, et al. CC Chemokines in a Tumor: A review of pro-cancer and anti-cancer properties of the ligands of receptors CCR1, CCR2, CCR3, and CCR4[J]. Int J Mol Sci, 2020, 21(21): 8412.
29 Ishida Y, Kuninaka Y, Yamamoto Y, et al. Pivotal involvement of the CX3CL1-CX3CR1 axis for the recruitment of M2 tumor-associated macrophages in skin carcinogenesis[J]. J Invest Dermatol, 2020, 140(10): 1951-1961.e6.
30 Yang H, Zhang Q, Xu M, et al. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis[J]. Mol Cancer, 2020, 19(1): 41.
31 Tang ZR, Zhang R, Lian ZX, et al. Estrogen-receptor expression and function in female reproductive disease[J]. Cells, 2019, 8(10): 1123.
32 Farcas AM, Nagarajan S, Cosulich S, et al. Genome-wide estrogen receptor activity in breast cancer[J]. Endocrinology, 2021, 162(2): 224.
33 Hwang NM, Stabile LP. Estrogen receptor ß in cancer: To ß(e)or not to ß(e)?[J]. Endocrinology, 2021, 162(11): 62.
34 He M, Yu W, Chang C, et al. Estrogen receptor α promotes lung cancer cell invasion via increase of and cross-talk with infiltrated macrophages through the CCL2/CCR2/MMP9 and CXCL12/CXCR4 signaling pathways[J]. Mol Oncol, 2020, 14(8): 1779-1799.
35 Gordon SR, Maute RL, Dulken BW, et al. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity[J]. Nature, 2017, 545(7655): 495-499.
36 Sepesi B, Cuentas EP, Canales JR, et al. Programmed death cell ligand 1(PD-L1)is associated with survival in stage I non-small cell lung cancer[J]. Semin Thorac Cardiovasc Surg, 2017, 29(3): 408-415.
37 Zhang X, Zeng Y, Qu Q, et al. PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer[J]. Int J Clin Oncol, 2017, 22(6): 1026-1033.
38 Zhang Y, Du W, Chen Z, et al. Upregulation of PD-L1 by SPP1 mediates macrophage polarization and facilitates immune escape in lung adenocarcinoma[J]. Exp Cell Res, 2017, 359(2): 449-457.
39 Liu Y, Zugazagoitia J, Ahmed FS, et al. Immune cell PD-L1 colocalizes with macrophages and is associated with outcome in PD-1 pathway blockade therapy[J]. Clin Cancer Res, 2020, 26(4): 970-977.
40 Martínez-Reyes I, Chandel NS. Cancer metabolism: looking forward[J]. Nat Rev Cancer, 2021, 21(10): 669-680.
41 Reina-Campos M, Moscat J, Diaz-Meco M. Metabolism shapes the tumor microenvironment[J]. Curr Opin Cell Biol, 2021, 48: 47-53.
42 Certo M, Tsai CH, Pucino V, et al. Lactate modulation of immune responses in inflammatory versus tumour microenvironments[J]. Nat Rev Immunol, 2021, 21(3): 151-161.
43 Harmon C, O'Farrelly C, Robinson MW. The immune consequences of lactate in the tumor microenvironment[J]. Adv Exp Med Biol, 2020, 1259: 113-124.
44 Mu X, Shi W, Xu Y, et al. Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK/STAT3 signaling pathway in breast cancer[J]. Cell Cycle, 2018, 17(4): 428-438.
45 Liu N, Luo J, Kuang D, et al. Lactate inhibits ATP6V0d2 expression in tumor-associated macrophages to promote HIF-2α-mediated tumor progression[J]. J Clin Invest, 2019, 129(2): 631-646.
46 Chinopoulos C. Succinate in ischemia: Where does it come from?[J]. Int J Biochem Cell Biol, 2019, 115: 105580.

备注/Memo

备注/Memo:

基金项目: 国家自然科学基金资助项目(31872634)
通信作者: 余 华, Email: peter.pan210@163.com
张克斌, Email: zhangkebin12@163.com

常用功能

更新日期/Last Update: 2022-10-20